Impact of Hepatopulmonary Syndrome on Quality of Life and Survival in Liver Transplant Candidates
To access this article, please choose from the options below
Supported by National Institutes of Health grants DK064103, DK065958, RR00645, RR00585, RR00046, RR00032, and HL67771.
The authors have no conflicts of interest to report.
The Pulmonary Vascular Complications of Liver Disease Study Group also includes the following: Columbia University: Jenna Reinen, BA, Jeffrey Okun, BA, Sonja Olsen, MD, Debbie Rybak, BA, Daniel Rabinowitz, PhD, Lori Rosenthal, NP, Evelyn M. Horn, MD; Mayo Clinic: Linda Stadheim, RN, Russell Wiesner, MD; University of Alabama: Dottie Faulk, J. Stevenson Bynon, MD, Devin Eckhoff, MD, Harpreet Singh, Rajasekhar Tanakella, Raymond Benza, MD; University of Colorado: David Badesch, MD, Ted Perry; University of North Carolina: Carrie Nielsen, RN, Roshan Shrestha, MD; University of Pennsylvania: Vivek Ahya, MD, Harold Palevsky, MD, Rajender Reddy, MD, Michael Harhay, Sandra Kaplan, RN, Darren Taichman, MD, PhD; University of Southern California, James Knowles, MD, PhD.
PII: S0016-5085(08)01089-5
doi:10.1053/j.gastro.2008.06.038
© 2008 AGA Institute. Published by Elsevier Inc. All rights reserved.


